ITI Securities Broking Ltd

Change Company Name

Lyka Labs Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 500259	ISIN Demat INE933A01014	Book Value 24.19	NSE Symbol LYKALABS	Div & Yield % 0	Market Cap (₹ Cr.) 244.46	P/E 0	EPS 0	Face Value 10

Particulars	Mar 2026	Dec 2025	Sep 2025	Jun 2025
	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Gross Sales	28.03	30.73	32.97	29.18
Other Operating Income	0.00	0.00	0.00	0.00
Other Income	0.51	1.37	1.21	0.67
Total Income	28.54	32.09	34.19	29.84
Total Expenditure	55.53	28.83	36.12	25.79
PBIDT	-26.99	3.26	-1.94	4.06
Interest	0.87	0.82	0.79	0.85
PBDT	-27.86	2.45	-2.73	3.20
Depreciation	2.04	2.15	2.07	2.03
Tax	0.34	0.00	0.18	0.31
Fringe Benefit Tax	0.00	0.00	0.00	0.00
Deferred Tax	-0.47	0.00	-1.35	0.05
Reported Profit After Tax	-29.77	0.29	-3.63	0.81
Extra-ordinary Items	-22.75	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-7.02	0.29	-3.63	0.81

EPS (Unit Curr.)	-8.34	0.08	-1.02	0.22
EPS (Adj) (Unit Curr.)	-8.34	0.08	-1.02	0.22
Calculated EPS (Unit Curr.)	-8.34	0.08	-1.02	0.23
Calculated EPS (Adj) (Unit Curr.)	-8.34	0.08	-1.02	0.23
Calculated EPS (Ann.) (Unit Curr.)	-33.37	0.33	-4.06	0.91
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-33.37	0.33	-4.06	0.91
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
Equity	35.69	35.69	35.69	35.69
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00

PBIDTM(%)	-96.29	10.61	-5.88	13.91
PBDTM(%)	-99.39	7.97	-8.28	10.97
PATM(%)	-106.21	0.94	-11.01	2.78
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00
Diluted EPS	-8.34	0.08	-1.02	0.22

Quarterly Results

Market

News

Research

TECHNICAL

FUNDAMENTAL

Products

Attention Investors